2025. Risk of urinary adverse effects of bevacizumab therapy in patients with ovarian cancer: a systematic review and meta-analysis. Archivio Italiano di Urologia e Andrologia. 97, 4 (Dec. 2025). DOI:https://doi.org/10.4081/aiua.2025.14659.